These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 16819435)
1. Allogeneic bone marrow transplantation for hypereosinophilic syndrome: long-term follow-up with eradication of FIP1L1-PDGFRA fusion transcript. Halaburda K; Prejzner W; Szatkowski D; Limon J; Hellmann A Bone Marrow Transplant; 2006 Aug; 38(4):319-20. PubMed ID: 16819435 [No Abstract] [Full Text] [Related]
2. Imatinib discontinuation for hypereosinophilic syndrome harboring the FIP1L1-PDGFRA transcript. Helbig G; Soja A; Świderska A; Hus M; Kyrcz-Krzemień S Leuk Lymphoma; 2016; 57(3):708-10. PubMed ID: 26430910 [No Abstract] [Full Text] [Related]
3. Maintenance therapy with imatinib appears necessary despite molecular remission in FIP1L1-PDGFRA fusion gene positive hypereosinophilic disorder. Ng HJ; Tan DC; Yiu RC; How GF Leuk Res; 2008 Jan; 32(1):169-71. PubMed ID: 17544504 [TBL] [Abstract][Full Text] [Related]
4. Detection of FIP1L1-PDGFRA fusion by FISH. Ma ES; Wong KF; Wong CL; Siu LL Br J Haematol; 2007 Aug; 138(3):279. PubMed ID: 17542982 [No Abstract] [Full Text] [Related]
5. Idiopathic hypereosinophilic syndrome in children: report of a 7-year-old boy with FIP1L1-PDGFRA rearrangement. Rives S; Alcorta I; Toll T; Tuset E; Estella J; Cross NC J Pediatr Hematol Oncol; 2005 Dec; 27(12):663-5. PubMed ID: 16344672 [TBL] [Abstract][Full Text] [Related]
6. Management of F/P+/- hypereosinophilic syndromes: case report and treatment review. Kalra A; Palaniswamy C; Kalra A; Wig N; Sood R Am J Ther; 2012 Sep; 19(5):e146-51. PubMed ID: 20724910 [TBL] [Abstract][Full Text] [Related]
7. Chronic eosinophilic leukaemia with FIP1L1-PDGFRA fusion and T6741 mutation that evolved from Langerhans cell histiocytosis with eosinophilia after chemotherapy. Ohnishi H; Kandabashi K; Maeda Y; Kawamura M; Watanabe T Br J Haematol; 2006 Sep; 134(5):547-9. PubMed ID: 16856885 [No Abstract] [Full Text] [Related]
8. Detection of the FIP1L1-PDGFRA fusion in idiopathic hypereosinophilic syndrome and chronic eosinophilic leukemia. Cools J; Stover EH; Gilliland DG Methods Mol Med; 2006; 125():177-87. PubMed ID: 16502585 [TBL] [Abstract][Full Text] [Related]
9. Rapid reversion of eosinophilic gastroenteritis associated with FIP1L1-PDGFRA fusion after targeted therapy with imatinib. Pitini V; Sturniolo G; Cavallari V; Arrigo C Br J Haematol; 2006 Jan; 132(2):123. PubMed ID: 16398645 [No Abstract] [Full Text] [Related]
10. Successful Heart Transplantation for Unreversible Endomyocardial Fibrosis Related to FIP1L1-PDGFRA Chronic Eosinophilic Leukemia. Fassnacht F; Roumier M; Fouret P; Levy V; Varnous S; Russel S; Lefevre G; Kahn JE Transplantation; 2015 Nov; 99(11):e176-7. PubMed ID: 26492057 [No Abstract] [Full Text] [Related]
11. Newly identified phenotypes in a FIP1L1/PDGFRA-associated paediatric HES patient: thrombocytosis, mHPA, young stroke and blindness. Zeng K; Li L; Huang L; Liang YH J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):614-6. PubMed ID: 24576219 [No Abstract] [Full Text] [Related]
12. F604S exchange in FIP1L1-PDGFRA enhances FIP1L1-PDGFRA protein stability via SHP-2 and SRC: a novel mode of kinase inhibitor resistance. Gorantla SP; Zirlik K; Reiter A; Yu C; Illert AL; Von Bubnoff N; Duyster J Leukemia; 2015 Aug; 29(8):1763-70. PubMed ID: 25761934 [TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias. Vandenberghe P; Wlodarska I; Michaux L; Zachée P; Boogaerts M; Vanstraelen D; Herregods MC; Van Hoof A; Selleslag D; Roufosse F; Maerevoet M; Verhoef G; Cools J; Gilliland DG; Hagemeijer A; Marynen P Leukemia; 2004 Apr; 18(4):734-42. PubMed ID: 14973504 [TBL] [Abstract][Full Text] [Related]
14. [Identification of FIP1L1-PDGFRA fusion, and expression of signal transducer and activator of transcription 5 in hypereosinophilic syndrome]. Zhang GS; Li B; Pei MF; Dai CW; Zheng WL; Shen JK Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(18):1541-4. PubMed ID: 15500716 [TBL] [Abstract][Full Text] [Related]
15. [Synchronous detection of T-cell clonality and FIP1L1-PDGFRA fusion gene in a hypereosinophilic syndrome]. Martinaud C; Souraud JB; Cournac JM; Pons S; Ménard G; de Jaureguiberry JP; Brisou P Rev Med Interne; 2011 May; 32(5):e66-8. PubMed ID: 20633965 [TBL] [Abstract][Full Text] [Related]
16. Imatinib mesylate can induce complete molecular remission in FIP1L1-PDGFR-a positive idiopathic hypereosinophilic syndrome. Martinelli G; Malagola M; Ottaviani E; Rosti G; Trabacchi E; Baccarani M Haematologica; 2004 Feb; 89(2):236-7. PubMed ID: 15003901 [No Abstract] [Full Text] [Related]
17. Synchronous FIP1L1-PDGFRA-positive chronic eosinophilic leukemia and T-cell lymphoblastic lymphoma: a bilineal clonal malignancy. Capovilla M; Cayuela JM; Bilhou-Nabera C; Gardin C; Letestu R; Baran-Marzak F; Fenaux P; Martin A Eur J Haematol; 2008 Jan; 80(1):81-6. PubMed ID: 18028420 [TBL] [Abstract][Full Text] [Related]
20. Clinical features of hypereosinophilic syndrome: FIP1L1-PDGFRA fusion gene-positive disease is a distinct clinical entity with myeloproliferative features and a poor response to corticosteroid. Miyazawa K; Kakazu N; Ohyashiki K Int J Hematol; 2007 Jan; 85(1):5-10. PubMed ID: 17261495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]